期刊文献+

血小板活化和内皮细胞损害对系统性红斑狼疮影响的临床研究 被引量:2

The Study on the Activation of Platelet and Injury of Endothelial cell Effects on Systemic Lupus Erythematosus
下载PDF
导出
摘要 目的研究血小板活化和内皮细胞损害对系统性红斑狼疮(SLE)的影响。方法采用放射免疫法和酶联免疫法测定66例SLE和40例正常人血浆血浆血栓烷B2(TXB2)、11-去氢-血栓烷B2(DH-TXB2)、血小板α-颗粒膜蛋白(GMP-140)、血管性血友病因子(vWF)、凝血酶调节蛋白(TM)水平。结果 (1)SLE无肾损害组:与对照组比较:治疗前DH-TXB2、GMP-140、TM升高(P<0.05),与治疗前比较:治疗后TXB2、DH-TXB2、GMP-140、vWF降低(P<0.05)。(2)SLE有肾损害组:与对照组比较:治疗前TXB2、DH-TXB2、GMP-140、vWF、TM升高(P<0.01);治疗后TXB2、DH-TXB2、GMP-140、vWF、TM升高(P<0.05-0.01);与治疗前比较:治疗后TXB2、DH-TXB2、GMP-140、vWF、TM降低(P<0.05)。结论 SLE患者存在血小板活化和内皮细胞损害,有肾损害组较显著,治疗后减轻。 Objective To study the effects of platelet activation and injury of endothelial cell on sys- temic lupus erythematosus (SLE) patients and their prognoses. Method Radio-immunity and ELISA were em- ployed to detect the TXB2, DH-TXB2, GMP-140, vWF,TM levels in 66 cases of SLE patients and 40 cases of the normal, healthy control person. Results ( 1 ) SLE with no renal damage group : contrast with the control groups:The levels of DH- TXB2, GMP- 140, TM increased before treatment ( P 〈 0.05 ) , while TXB2, DH- TXB2, GMP-140, vWF decreased after treatment( P 〈 0.05 ). (2)SLE with renal damage groups contrast with the control groups ; levels of TXB2, DH- TXB2, GMP- 140, vWF, TM increased before treatment ( P 〈 0.01 ) ; TXB2, DH- TXB2 , GMP- 140, vWF, TM increased after treatment ( P 〈 0.05 - 0.01 ) ; contrast with the before treatment groups, TXB2, DH- TXB2, GMP- 140, vWF, TM decreased ( P 〈 0.05 ) after treatment. Conclusion Activations of platelet and injuries of epithelium cells existed in SLE patients, and for renal damage pgroups is more seriously, after theray all have lessen.
出处 《血栓与止血学》 2013年第1期9-11,共3页 Chinese Journal of Thrombosis and Hemostasis
关键词 血小板活化 内皮细胞损害 系统性红斑狼疮 Platelet activation Epithelium injury Systemic lupus erythematosus
  • 相关文献

参考文献5

二级参考文献22

  • 1王兆钺,王山喜,阮长耿.11-去氢-血栓烷B_2测定及其临床应用[J].中华血液学杂志,1996,17(9):472-474. 被引量:20
  • 2Kaiser R,Cleveland CM,Criswell LA.Risk and protective factors for thrombosis in systemic lupus erythematosus:results from a large,multi-ethnic cohort[J].Ann Rheum Dis,2009,68 (2):238-241.
  • 3Romero-Diaz J,Garcia-Sosa I,Sanchez-Guerrero J.Thrombosis in systemic lupus erythematesus and other autoimmune diseases of recent ouset[J].J Rheumatol,2009,36(1):68 -75.
  • 4Tektonidou MG,Laskari K,Panagiotakos DB,et al.Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies[J].Arthritis Rheum,2009,61 (1):29 -36.
  • 5Choojitarom K,Verasertniyom O,Tctemehokchyakorn K,et al.Lupus nephritis and Raynaud's phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies[J].Clin Rheumatol,2008,27 (3):345-351.
  • 6Shaft ST,Gupta M.Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis[J].J Vasc Access,2007,8(2):103 -108.
  • 7Bizzaro N,Ghirardello A,Zampieri S,et al.Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus:a 15-year longitudinal study[J].J Thromb Haemost,2007,5(6):1158 -1164.
  • 8Bertolaccini ML,Mepani K,Sanna G,et al.Factor Ⅻ autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus[J].Ann Rheum Dis,2007,66(4):533 -536.
  • 9Wu H,Birmingham DJ,Rovin B,et al.D-dimer level and the risk for thrombosis in systemic lupus erythematosus[J].Clin J Am Soc Nephrol,2008,3 (6):1628-1636.
  • 10Meesters EW,Hausen H,Spronk HM,et al.The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus[J].Blood Coagul Fihrinolysis,2007,18(1):21 -28.

共引文献38

同被引文献30

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部